Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,140.00
-20.00 (-0.32%)
At close: Sep 11, 2026

KOSDAQ:036480 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
350.78598.19-1,769-679.681,703865.92
Depreciation & Amortization
2,5192,5401,7152,8622,7062,538
Loss (Gain) From Sale of Assets
-14.22-19.04-16.260.07-2,219-7
Loss (Gain) From Sale of Investments
0.20.070.190.290.910.3
Loss (Gain) on Equity Investments
27.4338.727.7-36.3914.64.97
Provision & Write-off of Bad Debts
253.7174.93170.8227.0929.4212.07
Other Operating Activities
-670.5945.76887.1-342.66881.17367.84
Change in Accounts Receivable
-544.03-1,403229.73-1,130-103.07516.13
Change in Inventory
-511.57311.621,536-1,132-1,027-1,417
Change in Accounts Payable
224.57-190.91-226.87565.26209.1-468.3
Change in Other Net Operating Assets
-660.07-686.04-450.67-1,368-1,039-209.63
Operating Cash Flow
974.731,4102,103-1,2341,1552,203
Operating Cash Flow Growth
-64.98%-32.95%---47.56%-31.92%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-358.21-355.64-795.32-1,256-2,315-2,968
Sale of Property, Plant & Equipment
15.4619.0518.6459.094,5727
Sale (Purchase) of Intangibles
-0.52-2.45-0.55-3.96-0.39-0.8
Investment in Securities
-1,664-322.852,1971,437-3,415-678.96
Other Investing Activities
900--00
Investing Cash Flow
-1,917-661.891,419235.73-1,158-3,641

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,5001,0003,3192,000700
Long-Term Debt Issued
--15,5003,000-800
Total Debt Issued
3,9851,50016,5006,3192,0001,500
Short-Term Debt Repaid
--1,000-5,319--700-700
Long-Term Debt Repaid
--1,038-15,374-4,553-1,661-172.18
Total Debt Repaid
-5,026-2,038-20,692-4,553-2,361-872.18
Net Debt Issued (Repaid)
-1,041-537.86-4,1921,766-361.29627.82
Dividends Paid
-285-285-285-285-285-323
Other Financing Activities
------0
Financing Cash Flow
-1,326-822.86-4,4771,481-646.29304.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
235.63-110.12222.8428.2105.91316.07
Miscellaneous Cash Flow Adjustments
-0-000-0
Net Cash Flow
-2,033-184.76-731.96510.68-543.44-816.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
616.511,0541,308-2,490-1,160-764.71
Free Cash Flow Growth
-73.26%-19.37%----
Free Cash Flow Margin
2.45%4.06%5.49%-9.74%-4.55%-3.19%
Free Cash Flow Per Share
-277.49344.14-655.25-305.18-201.24
Levered Free Cash Flow
248.51652.321,543-1,862-997.53-1,065
Unlevered Free Cash Flow
615.771,0312,072-1,304-677.16-891.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
574.77592.29909.4955.25458.48271.46
Cash Income Tax Paid
8.27-6.08-52.12475.446.03-94.73
Change in Working Capital
-1,491-1,9691,088-3,065-1,961-1,579